Moderna’s stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the biotechnology company’s vaccines and said it would cancel some contracts and stop funding mRNA drug development.